530 related articles for article (PubMed ID: 30787188)
21. Long-term expanding human airway organoids for disease modeling.
Sachs N; Papaspyropoulos A; Zomer-van Ommen DD; Heo I; Böttinger L; Klay D; Weeber F; Huelsz-Prince G; Iakobachvili N; Amatngalim GD; de Ligt J; van Hoeck A; Proost N; Viveen MC; Lyubimova A; Teeven L; Derakhshan S; Korving J; Begthel H; Dekkers JF; Kumawat K; Ramos E; van Oosterhout MF; Offerhaus GJ; Wiener DJ; Olimpio EP; Dijkstra KK; Smit EF; van der Linden M; Jaksani S; van de Ven M; Jonkers J; Rios AC; Voest EE; van Moorsel CH; van der Ent CK; Cuppen E; van Oudenaarden A; Coenjaerts FE; Meyaard L; Bont LJ; Peters PJ; Tans SJ; van Zon JS; Boj SF; Vries RG; Beekman JM; Clevers H
EMBO J; 2019 Feb; 38(4):. PubMed ID: 30643021
[TBL] [Abstract][Full Text] [Related]
22. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
23. [Organoids as a milestone on the way to personalized treatment of urothelial carcinoma: a systematic review].
Melzer MK; Zehe V; Zengerling F; Wezel F; Günes C; Maisch P; Bolenz C
Urologie; 2022 Jul; 61(7):745-752. PubMed ID: 35925247
[TBL] [Abstract][Full Text] [Related]
24. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.
Nuciforo S; Fofana I; Matter MS; Blumer T; Calabrese D; Boldanova T; Piscuoglio S; Wieland S; Ringnalda F; Schwank G; Terracciano LM; Ng CKY; Heim MH
Cell Rep; 2018 Jul; 24(5):1363-1376. PubMed ID: 30067989
[TBL] [Abstract][Full Text] [Related]
25. Human gastric cancer modelling using organoids.
Seidlitz T; Merker SR; Rothe A; Zakrzewski F; von Neubeck C; Grützmann K; Sommer U; Schweitzer C; Schölch S; Uhlemann H; Gaebler AM; Werner K; Krause M; Baretton GB; Welsch T; Koo BK; Aust DE; Klink B; Weitz J; Stange DE
Gut; 2019 Feb; 68(2):207-217. PubMed ID: 29703791
[TBL] [Abstract][Full Text] [Related]
26. SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.
Tan P; Wang M; Zhong A; Wang Y; Du J; Wang J; Qi L; Bi Z; Zhang P; Lin T; Zhang J; Yang L; Chen J; Han P; Gong Q; Liu Y; Chen C; Wei Q
Oncogene; 2021 Oct; 40(42):6081-6092. PubMed ID: 34471236
[TBL] [Abstract][Full Text] [Related]
27. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
28. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
29. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
[TBL] [Abstract][Full Text] [Related]
30. Characterization of organoid cultured human breast cancer.
Goldhammer N; Kim J; Timmermans-Wielenga V; Petersen OW
Breast Cancer Res; 2019 Dec; 21(1):141. PubMed ID: 31829259
[TBL] [Abstract][Full Text] [Related]
31. No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.
Otto W; Denzinger S; Bertz S; Gaumann A; Wild PJ; Hartmann A; Stoehr R
Int J Cancer; 2009 Nov; 125(9):2205-8. PubMed ID: 19621447
[TBL] [Abstract][Full Text] [Related]
32. Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.
Smith YC; Grande KK; Rasmussen SB; O'Brien AD
Infect Immun; 2006 Jan; 74(1):750-7. PubMed ID: 16369034
[TBL] [Abstract][Full Text] [Related]
33. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
34. The potential of organoids in urological cancer research.
Wang S; Gao D; Chen Y
Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
[TBL] [Abstract][Full Text] [Related]
35. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
Kim YS; Hsieh AC; Lam HM
Eur Urol Focus; 2022 May; 8(3):657-659. PubMed ID: 35915037
[TBL] [Abstract][Full Text] [Related]
36. Prospective derivation of a living organoid biobank of colorectal cancer patients.
van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
[TBL] [Abstract][Full Text] [Related]
37. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathways of urothelial development and bladder tumorigenesis.
Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
[TBL] [Abstract][Full Text] [Related]
39. Kras in Organoids.
Cheng D; Tuveson D
Cold Spring Harb Perspect Med; 2018 Oct; 8(10):. PubMed ID: 29311127
[TBL] [Abstract][Full Text] [Related]
40. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]